Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Koll Florestan Johannes |

Presentations at scientific and public conferences

Koll, F Ausblick Uroonkologie Blase, Niere & Prostata 2025 - Wohin geht die Reise?
Urogenitale Tumore - facts & consequences 2025; MAR 27, 2025; Graz, AUSTRIA. 2025. [Oral Communication]
FullText

Koll, FJ; Wenzel, M; Banek, S; Köllermann, J; Kluth, L; Cano Garcia, C; Schupp, J; Chun, F; Wild, P; Reis, H Deciphering the tumor microenvironment of metastatic urothelial carcinoma using spatial profiling to identify associations with immunotherapy response
Eur Urol Suppl 2025/S;87 (S 1). 2025; -40th Annual EAU Congress; MAR 21-24, 2025; Mardid, SPAIN. [Oral Communication]
FullText

Koll, F; Döring, C; Herwig, L; Hoeh, B; Wenzel, M; Cano Garcia, C; Banek, S; Kluth, L; Köllermann, J; Chun, F; Wild, P; Reis, H Molekulare Subtypen des muskelinvasiven Harnblasenkarzinoms - Untersuchung von histologischen Subtypen, Tumor-Mikroumgebung und Überleben
10.3205/24swdgu58. 2024; -64. Jahrestagung der Südwestdeutschen Gesellschaft für Urologie e.V.; JUN 19-22, 2024 ; Freiburg, AUSTRIA. [Oral Communication]
FullText

Koll, FJ; Basar, M; Chen, Z; Tin, AL; Alam, SM; Tallman, JE; Clinton, TN; Whiting, K; Chen, JF; Sarungbam, J; Sirintrapun, SJ; Gopalan, A; Chen, YB; Fine, SW; Tickoo, SK; Pietzak, E; Iyer, G; Rosenberg, JE; Bajorin, DF; Bochner, BH; Reuter, VE; Gao, SP; Solit, DB; Al-Ahmadie, H Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
European Urology . 2024; 85: S874--39th Annual European Association of Urology Congress (EAU) 2024; Apr 05 - 08, 2024 ; Paris, FRANCE. [Oral Communication]

Tallman, JE; Kuo, F; Alam, SM; Koll, F; Luo, J; Gao, SP; Pietzak, EJ; Iyer, G; Solit, DB; Al-Ahmadie, H Abstract A029: Transcriptome analysis of variant histology bladder cancer reveals drug target heterogeneity
Clin Cancer Res 2024;30(10_Suppl):Abstract nr A029.. 2024; -AACR Special Conference on Bladder Cancer; May 17-20, 2024; Philadelphia, USA.

Koll, F Was ist aus der SWDGU Forschungsförderung 2022 geworden? - Untersuchung der immunmodulierenden Funktion des Growth/Differentiation Factor-15 (GDF-15) beim muskelinvasiven Blasenkarzinom
JAHRESTAGUNG der Südwestdeutschen Gesellschaft für Urologie (SWDGU); JUN 21-24, 2023; Reutlingen, DEUTSCHLAND. 2023. [Oral Communication]

Koll, F; Banek, S; Kluth, L; Köllermann, J; Weigert, A; Chun, F; Wild, P; Reis, H MP14-15 MACROPHAGES AND REGULATORY T-CELLS AS PROGNOSTIC FACTORS IN PATIENTS WITH UROTHELIAL MUSCLE-INVASIVE BLADDER CANCER
The Journal of Urology 209(Supplement 4):p e188. 2023; -American Urological Association's 2023 Annual Meeting; APR 28 - MAY 1, 2023; Chicago, USA. [Oral Communication]
FullText

Koll, F; Banek, S; Kluth, L; Weigert, A; Köllermann, J; Chun, F; Wild, P; Reis, H Makrophagen und regulatorische T-Zellen als prognostischer Faktor bei Patienten mit muskelinvasivem Blasenkarzinom
13. Symposium des Deutschen Forschungsverbund Blasenkarzinom e.V. ; MAR 24-25, 2023; Berlin, DEUTSCHLAND. 2023. [Oral Communication]

Koll, F; Rammal, R; Chen, Z; Basar, M; Alam, SM; Tallman, JE; Pietzak, E; Dalbagni, G; Donahue, T; Donat, SM; Bochner, B; Rosenberg, J; Iyer, G; Solit, D; Al-Ahmadie, H CLINICAL, MOLECULAR AND IMMUNOHISTOCHEMICAL PROFILES OF CLEAR CELL ADENOCARCINOMA OF THE URINARY TRACT
Urologic Oncology: Seminars and Original Investigations. 2023; 42: S35--24th Annual Meeting of the Society of Urologic Oncology ; NOV 28 - DEC 1, 2023; Washington DC, USA. [Poster]
FullText

Koll, F; Weers, L; Weigert, A; Köllermann, J; Szarvas, T; Döring, C; Chun, F; Wild, P; Reis, H Umfassende Charakterisierung des lymphoepithelialen Urothelkarzinoms der Harnblase
13. Symposium des Deutschen Forschungsverbund Blasenkarzinom e.V.; MAR 24-25, 2023; Berlin, DEUTSCHLAND. 2023. [Oral Communication]

Koll, F; Kluth, L; Chun, F; Banek, S; Bankov, K; Köllermann, J; Reis, H; Wild, P MP03-09 IMPACT OF VARIANT HISTOLOGY AND IMMUNOHISTOCHEMISTRY ON RESPONSE TO ADJUVANT CHEMOTHERAPY IN UROTHELIAL MUSCLE-INVASIVE BLADDER CANCER
Journal of Urology;207(Supplement 5):e23 . 2022; -American Urological Association's 2022 Annual Meeting, May 13 - 16, 2022 in New Orleans; May 13 - 16, 2022; New Orleans, USA. [Oral Communication]
FullText

Koll, FJ; Banek, S; Kluth, L; Bankov, K; Döring, C; Weigert, A; Macinkovic, I; Chun, F; Wild, PJ; Reis H Characterization of molecular stroma-rich muscle-invasive bladder cancer
25th Anniversary Meeting of the International Bladder Cancer Network (IBCN); SEP 29 - OCT 1 2022; Barcelona, Spain. 2022. [Poster]

Koll, FJ; Mantwill, K; Schmid, SC; Multhoff, G; Gschwend, JE; Nawroth, R; Holm, PS 32 Treatment of bladder cancer with YB-1 dependent oncolytic adenovirus: Preliminary in vitro studies
European Urology Supplements. 2015; 14(2):e32--40th Annual EAU Congress (EAU25); MAR 20-24, 2015; Madrid, Spain. [Oral Communication]
FullText

↑ Top of page / Navigation